Literature DB >> 22496581

Why are upper motor neuron signs difficult to elicit in amyotrophic lateral sclerosis?

Michael Swash1.   

Abstract

It is often difficult to identify signs of upper motor neuron lesion in the limbs of patients with amyotrophic lateral sclerosis, in whom there is neurogenic muscle wasting of varying severity. The reasons for this are complex and not related simply to the degree of lower motor neuron muscle wasting but, rather, depend on the pathophysiological abnormalities that develop in response to damage to descending motor pathways and to motor neurons and interneurons in the ventral horns of the spinal cord. The different mechanisms underlying the clinical phenomenology of the functional motor defect in amyotrophic lateral sclerosis, that lead to difficulty in detecting classical upper motor neuron signs, are discussed.

Entities:  

Mesh:

Year:  2012        PMID: 22496581     DOI: 10.1136/jnnp-2012-302315

Source DB:  PubMed          Journal:  J Neurol Neurosurg Psychiatry        ISSN: 0022-3050            Impact factor:   10.154


  26 in total

1.  Dissociated lower limb muscle involvement in amyotrophic lateral sclerosis.

Authors:  Neil G Simon; Michael Lee; Jong Seok Bae; Eneida Mioshi; Cindy S-Y Lin; Casey M Pfluger; Robert D Henderson; Steve Vucic; Michael Swash; David Burke; Matthew C Kiernan
Journal:  J Neurol       Date:  2015-04-07       Impact factor: 4.849

2.  Neurochemical correlates of functional decline in amyotrophic lateral sclerosis.

Authors:  Ian Cheong; Dinesh K Deelchand; Lynn E Eberly; Małgorzata Marjańska; Georgios Manousakis; Gaurav Guliani; David Walk; Gülin Öz
Journal:  J Neurol Neurosurg Psychiatry       Date:  2018-11-22       Impact factor: 10.154

3.  MR Imaging-based Estimation of Upper Motor Neuron Density in Patients with Amyotrophic Lateral Sclerosis: A Feasibility Study.

Authors:  Jacqueline Chen; Volodymyr Kostenko; Erik P Pioro; Bruce D Trapp
Journal:  Radiology       Date:  2018-01-23       Impact factor: 11.105

Review 4.  Transcranial Magnetic Stimulation for the Assessment of Neurodegenerative Disease.

Authors:  Steve Vucic; Matthew C Kiernan
Journal:  Neurotherapeutics       Date:  2017-01       Impact factor: 7.620

5.  Safety and efficacy of botulinum toxin A for the treatment of spasticity in amyotrophic lateral sclerosis: results of a pilot study.

Authors:  Juan F Vázquez-Costa; Inmaculada Máñez; Ana Alabajos; Maricruz Guevara Salazar; Cristina Roda; Teresa Sevilla
Journal:  J Neurol       Date:  2016-07-06       Impact factor: 4.849

Review 6.  Pathophysiological and diagnostic implications of cortical dysfunction in ALS.

Authors:  Nimeshan Geevasinga; Parvathi Menon; P Hande Özdinler; Matthew C Kiernan; Steve Vucic
Journal:  Nat Rev Neurol       Date:  2016-09-23       Impact factor: 42.937

7.  The puzzling case of hyperexcitability in amyotrophic lateral sclerosis.

Authors:  Jong Seok Bae; Neil G Simon; Parvathi Menon; Steve Vucic; Matthew C Kiernan
Journal:  J Clin Neurol       Date:  2013-04-04       Impact factor: 3.077

Review 8.  Role of Magnetic Resonance Imaging in Diagnosis of Motor Neuron Disease: Literature Review and Two Case Illustrations.

Authors:  Khalid Sawalha; Eduardo Gonzalez-Toledo; Omar Hussein
Journal:  Perm J       Date:  2019

9.  Genetic overlap between apparently sporadic motor neuron diseases.

Authors:  Marka van Blitterswijk; Lotte Vlam; Michael A van Es; W-Ludo van der Pol; Eric A M Hennekam; Dennis Dooijes; Helenius J Schelhaas; Anneke J van der Kooi; Marianne de Visser; Jan H Veldink; Leonard H van den Berg
Journal:  PLoS One       Date:  2012-11-14       Impact factor: 3.240

10.  Differential motor neuron involvement in progressive muscular atrophy: a comparative study with amyotrophic lateral sclerosis.

Authors:  Yuichi Riku; Naoki Atsuta; Mari Yoshida; Shinsui Tatsumi; Yasushi Iwasaki; Maya Mimuro; Hirohisa Watanabe; Mizuki Ito; Jo Senda; Ryoichi Nakamura; Haruki Koike; Gen Sobue
Journal:  BMJ Open       Date:  2014-05-14       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.